Amphastar Pharmaceuticals, Inc. (AMPH) Financials
AMPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | 1.7 billion | 897.2 million |
| June 30, 2026 | 1.7 billion | 975.6 million |
| March 31, 2026 | 1.6 billion | 874.8 million |
| Dec. 31, 2025 | 1.6 billion | 840.5 million |
AMPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | 33.4 million | 7.0 million |
| June 30, 2026 | 42.7 million | 7.1 million |
| March 31, 2026 | 38.3 million | 9.3 million |
| Dec. 31, 2025 | 24.6 million | 6.2 million |
AMPH Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Sept. 30, 2026 | 37.8 million |
| June 30, 2026 | 30.3 million |
| March 31, 2026 | 6.4 million |
| Dec. 31, 2025 | 24.4 million |
AMPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | 230.6 million | 610.5 million | 78.7 million |
| June 30, 2026 | 290.1 million | 609.6 million | 76.3 million |
| March 31, 2026 | 294.4 million | 609.8 million | 65.2 million |
| Dec. 31, 2025 | 282.8 million | 608.7 million | 45.6 million |
AMPH Shares Outstanding
AMPH Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | 9.9 million | 20.1 million | 28.8 million | 11.9 million |
| June 30, 2026 | 8.6 million | 22.2 million | 31.6 million | 13.3 million |
| March 31, 2026 | 9.5 million | 26.7 million | 30.0 million | 11.9 million |
| Dec. 31, 2025 | 8.3 million | 23.3 million | 26.8 million | 10.3 million |
AMPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 207.6 million | 108.0 million |
| June 30, 2026 | 183.9 million | 90.4 million |
| March 31, 2026 | 171.2 million | 100.8 million |
| Dec. 31, 2025 | 183.1 million | 97.4 million |
AMPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.
AMPH
Price: $29.40
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.18 USD
P/E Ratio: 13.33
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 105125
Ebitda: 2.1 millionMarket Capitalization: 1.2 billion